Huzursuz Bacak Sendromu: Güncel Tanı ve Tedavi

Yazarlar

Özet

Referanslar

Ekbom KA. Restless legs syndrome. Neurology. 1960;10(9):868-.

Gossard TR, Trotti LM, Videnovic A, St Louis EK. Restless Legs Syndrome: Contemporary Diagnosis and Treatment. Neurotherapeutics. 2021 Jan;18(1):140-155. doi: 10.1007/s13311-021-01019-4. Epub 2021 Apr 20. PMID: 33880737; PMCID: PMC8116476.

Çakmur R. Günal Dİ, Hareket Bozuklukları Tanı ve Tedavi Rehberi, 2. Baskı, Ankara, Türk Nöroloji Derneği Yayınları, 2023.

Ceylan M, Aygül R, Yalçın A, Erzurum ili huzursuz bacak sendromu prevelansının

Araştırılması ve sosyodemografik özelliklerin incelenmesi, J Contemp Med 2019;9(1):48-54, DOI: 10.16899/gopctd.448777

Allen RP, Picchietti DL, Garcia-Borreguero D et al. Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IHBSSG) consensus criteria--history, rationale, description, and signifcance. Sleep Med. 2014;15(8):860-73.

Akçimen F, Chia R, Saez-Atienzar S, Ruffo P, Rasheed M, Ross JP, Liao C, Ray A, Dion PA, Scholz SW, Rouleau GA, Traynor BJ. Genomic Analysis Identifies Risk Factors in Restless Legs Syndrome. Ann Neurol. 2024 Nov;96(5):994-1005. doi: 10.1002/ana.27040. Epub 2024 Jul 30. PMID: 39078117; PMCID: PMC11496024.

Winkelmann J, Wetter TC, Collado-Seidel V et al. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep. 2000;23(5):597-602.

Schormair B, Zhao C, Bell S et al. Identifcation of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis. Lancet Neurol. 2017;16(11):898-907.

Kaplan Ö, Başer M, Karaçam Z. Effect of Non-Pharmacological Methods Used for Restless Leg Syndrome in Pregnancy on the Severity of the Syndrome and Sleep: A Systematic Review and Meta-Analysis. Altern Ther Health Med. 2024 Jun;30(6):32-38. PMID: 39038317.

Silber MH, Becker PM, Earley C, Garcia-Borreguero D, Ondo WG. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome. Mayo Clin Proc. 2013;88(9):977-86.

Qadri SN, Jamil S, Zahid S, Asghar T, Gillani SM, Qasim SA, Kambar T, Abideen ZU, Brohi U, Tareen SK, Tareen PK, Kumari S, Kumar S, Khatri M. Clinical efficacy and safety of IV ferric carboxymaltose in restless legs syndrome: A meta-analysis of 537 patients. Sleep Med. 2024 Dec; 124:244-253. doi: 10.1016/j.sleep.2024.09.017. Epub 2024 Sep 18. PMID: 39326219.).

Inoue Y, Hirata K, Hoshino Y, Yamaguchi Y. Difference in background factors between responders to gabapentin enacarbil treatment and responders to placebo: pooled analyses of two randomized, double-blind, placebo-controlled studies in Japanese patients with restless legs syndrome. Sleep Med. 2021 Sep; 85:138-146. doi: 10.1016/j.sleep.2021.07.004. Epub 2021 Jul 7. PMID: 34329897.].

Garcia-Borreguero D, Larrosa O, de la Llave Y et al. Treatment of restless legs syndrome with gabapentin: a double-blind, crossover study. Neurology. 2002;59(10):1573-9.

Winkelman JW, Berkowski JA, DelRosso LM, Koo BB, Scharf MT, Sharon D, Zak RS, Kazmi U, Falck-Ytter Y, Shelgikar AV, Trotti LM, Walters AS. Treatment of restless legs syndrome and periodic limb movement disorder: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2025 Jan 1;21(1):137-152. doi: 10.5664/jcsm.11390. PMID: 39324694; PMCID: PMC11701286.)

Safarpour Y, Vaziri ND, Jabbari B. Restless Legs Syndrome in Chronic Kidney Disease- a Systematic Review. Tremor Other Hyperkinet Mov (N Y). 2023 Mar 29;13:10. doi: 10.5334/tohm.752. PMID: 37008995; PMCID: PMC10064886.).

Yeh WC, Li YS, Chang YP, Hsu CY. Dopamine agonists in restless leg syndrome treatment and their effects on sleep parameters: A systematic review and meta-analysis. Sleep Med. 2024 Jul; 119:379-388. doi: 10.1016/j.sleep.2024.05.011. Epub 2024 May 10. PMID: 38761607.).

Ondo WG. Methadone for refractory restless legs syndrome. Movement Disorders. 2005;20(3):345-8.

Lugo RA, Satterfeld KL, Kern SE. Pharmacokinetics of methadone. J Pain Palliat Care Pharmacother. 2005;19(4):13-24.

Gelecek

21 Ocak 2026

Lisans

Lisans